Table 1 Clinical and biochemical characteristics for the total 174 ESRD patients and for two subgroups based according to CAC score

 Age, years

57 (29, 75)

41 (23, 63)

64 (49, 78)

 Male, %

63

57

67

 Diabetes, %

28

10

40

 CVD, %

22

3

36

 Body mass index, kg/m²

24.8 (19.9, 30.8)

23.9 (19.7, 30.7)

25.2 (20.7, 30.8)

 Systolic BP, mmHg

139 (114, 169)

135 (114, 163)

143 (113, 179)

 Diastolic BP, mmHg

83 (67, 97)

85 (70, 100)

81 (66, 96)

 Hemoglobin, g/L

114 (94, 130)

113 (92, 128)

114 (100, 130)

 Triglycerides, mmol/L

1.6 (0.9, 3.0)

1.6 (0.9, 2.8)

1.4 (0.9, 3.6)

 Cholesterol, mmol/L

4.7 (3.3, 6.6)

4.6 (3.4, 6.1)

4.6 (3.0, 5.7)

 HDL-cholesterol, mmol/L

1.2 (0.8, 2.3)

1.4 (0.9, 2.4)

1.1 (0.9, 2.3)

 Creatinine, μmol/L

727 (491, 1012)

738 (509, 1185)

729 (414, 981)

 S-albumin, g/L

33 (26, 39)

35 (28, 40)

32 (23, 38)

 hsCRP, mg/L

2.1 (0.4, 18.7)

1.2 (0.2, 9.1)

3.6 (0.8, 35.4)

 TNF, pg/ml ^a

15.3 (9.9, 20.4)

12.9 (8.0, 19.8)

16.7 (12.0, 20.7)

 IL-6, pg/ml ^b

4.5 (0.9, 14.9)

2.1 (0.4, 8.1)

6.9 (2.2, 20.5)

 PTX3 ng/mL ^c

1.7 (0.7, 6.2)

1.8 (0.6, 7.1)

1.7 (0.7, 7.1)

 Total testosterone in male, nmol/L^d

11.0 (5.8, 20.5)

12.2 (7.4, 25.6)

10.2 (4.7, 16.9)

 iPTH, ng/L

300 (96, 655)

265 (113, 658)

320 (79, 735)

 Calcium, mmol/L

2.3 (2.0, 2.5)

2.3 (2.1, 2.5)

2.2 (1.9, 2.6)

 Phosphate, mmol/L

1.8 (1.2, 2.5)

1.9 (1.2, 2.4)

1.8 (1.2, 2.6)

 1,25-OH vitamin D, nmol/L ^e

13 (9, 28)

16.5 (9, 34)

11 (9, 23)

 25-OH vitamin D, ng/L ^f

29 (13, 70)

33 (14, 57)

29 (14, 80)

 tBMD, g/cm²

1.12 (0.92, 1.30)

1.13 (1.00, 1.31)

1.10 (0.91, 1.27)

 T-score of tBMD

−0.8 (−2.7, 1.1)

− 0.6 (− 2.0, 1.2)

−1.1 (− 3.1, 1.1)

 Z-score of tBMD

− 0.4 (− 1.8, 1.2)

− 0.1 (− 1.5, 1.1)

− 0.5 (− 2.4, 1.3)